Tau Protein Pathology in Alzheimer's disease
This short animation combines the lifework of Professor Claude Wischik, CEO of TauRx and the TauRx team on tau protein pathology in Alzheimer's Disease.
Embed this video on another site
Link to this video
About Us
TauRx is a global leader in tau-based Alzheimer’s disease research with a mission to discover, develop and commercialise innovative products for the diagnosis and treatment of neurodegenerative diseases caused by protein aggregation. The results of their current late-stage clinical trial, advancing a potential disease modifying treatment for Alzheimer’s Disease, are due to be announced mid-2022. Find out more at www.taurx.com